---
$id: https://graph.org.ai/products/commodity/51131653
$type: Product
source: UNSPSC
code: "51131653"
title: "Ticlopidine"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ticlopidine

**UNSPSC Code**: 51131653
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thienopyridine antiplatelet agent with the molecular formula C14H14ClNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OM90ZUW7M1, chemically known as 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine but generally known as ticlopidine, which bears US NIH Compound Identifier 5472. European Medicines Agency schedules Ticlopidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11028MIG. The term TICLOPIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules ticlopidine in its Anatomical Therapeutic Chemical (ATC) Classification. TICLOPIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ticlopidine under HS 29349990 and SITC 51579. As of Q4 2014, TICLOPIDINE remains the US FDA Preferred Term for this commodity. Ticlopidine bears US NLM identifiers UMLS ID C0040207 and NCI Concept Code C61972. SMILES: CLC1C(CN2CCC3SCCC3C2)CCCC1.

